(c) Myeloid cell activation (CD68) and infiltration (F4/80) in glioma mass in mice treated with IL-15 or vehicle, as shown in (a), analyzed at the end of treatment (17 days after glioma transplantation). The gene discussed is CD68; the disease is central nervous system cancer.